1/1/2026CDE Releases Technical Guidelines for Targeted Biologics in Chronic Ai...

1/1/2026CDE Issues Technical Guidelines for Clinical Trials of Drugs Treating ...

1/1/2026CDE Issues Technical Guidelines for Clinical Trials of Eosinophilic Es...

1/1/2026CDE Issues the Technical Guidelines for Using Single-Arm Clinical Tria...

1/1/2026China's Supreme Court Upholds Semaglutide Patent, Strengthening IP Pro...

1/1/2026Eli Lilly Slashes Mounjaro Price in China, Sparking Fierce Weight-Loss...

12/30/2025Innovent Submits Clinical Trial Application for Novel Bispecific Dual-...

12/30/2025Simcere Registers Phase 1 MRCT for EGFR/c-Met Bispecific ADC SIM0610 i...

12/30/2025AstraZeneca's Fasenra Approved for EGPA in China

12/30/2025China Approves AstraZeneca and Ionis' Wainua for ATTRv-PN

12/30/2025Innovent's Ipilimumab IBI310 for Neoadjuvant Therapy approved in China

12/30/2025AstraZeneca and Daiichi Sankyo Secures Chinese Approval of Enhertu fo...

12/30/2025Adlai Nortye Grants ASK Pharma Exclusive Rights for Pan-RAS Inhibitor ...

12/30/2025China Rejects Tianmai Biotech's Oral Insulin Capsule ORMD-0801

12/30/2025Novo Nordisk Cuts Price of Wegovy in China Ahead of Patent Expiry

12/30/2025Recbio's Files NDA for Shingles Vaccine REC610 China

12/30/2025HUTCHMED's Fanregratinib NDA Granted Priority Review in China

12/30/2025Ultra-Low Flu Shot Prices Highlight Intensifying Pressure on China's V...

12/30/2025Suzhou Launches China's First Nuclear Medicine Demonstration Base

12/30/2025China's Beautiful Biotech Chaos vs West's Elegant Paralysis (Asia Time...

12/27/2025China Biotech Raises $362 Million in 18 Financing Deals in November 20...

12/27/2025China Leads Globally in mRNA-Based Therapeutic Vaccine Development for...

12/27/2025Coherent Licenses CBP-1018 to MultiValent Biotherapies in Major Global...

12/27/2025China Approves GSK's Nucala for Maintenance Treatment of Eosinophilic ...

12/27/2025Novo Nordisk's Wegovy Approved in China for Cardiovascular Risk Reduct...

12/27/2025NMPA Approves Amgen/UCB's Evenity for Postmenopausal Osteoporosis

12/27/2025Guangzhou Novaken Pharm Files for HKSE Main Board Listing

12/27/2025GRIT's Next-Generation Gene-Edited TIL GT307 Receives FDA IND Approval

12/27/2025Frontera's HKSE IPO Application Accepted

12/27/2025Zai Lab's COBENFY Approve in China for Schizophrenia

Page:27/834 Total number of articles:25002: [First][<<] [25] [26] [27] [28] [29] [>>] [End]